Navigation Links
Elbit Medical Imaging Ltd. Announces Definitive Agreements for a Large Scale Luxury Mixed Use Project in Bangalore, India
Date:10/22/2007

TEL-AVIV, Israel, Oct. 22 /PRNewswire-FirstCall/ -- Elbit Medical Imaging Ltd. (Nasdaq: EMITF) ("EMI") today announced that on October 18, 2007 its wholly owned subsidiary has entered into definitive agreements with one of the leading developers in Bangalore, India (the "Partner") for the joint development of a large scale mixed-use project located in Bangalore, Karnataka, India.

The Project, which will be developed through an Indian company to be held in equal parts by EMI and the Partner (the "JV Company"), will be built in an upscale section of Bangalore, on an area of approximately 200 acres (by way of direct ownership) and additional areas through joint development rights. The Project is planned to include (i) high class residential neighborhoods with amenities such as a golf course, club houses, swimming pools, tennis courts, sports facilities and other recreation areas; (ii) office complexes and IT parks; (iii) a luxury 5 star+ hotel; (iv) a serviced apartments facility; (v) a hospital; and (vi) a major retail facility. The total built up area of the entire planned project will exceed 2 million square meters (approximately 21 million square feet), subject to obtaining the requisite permits and approvals under applicable law.

Construction of the Project is anticipated to commence within the next twelve months, and will be executed in stages to be completed within 3 to 5 years thereafter. The Project is the largest development project undertaken in the Bangalore area to date.

Consummation of the transaction will be accomplished in stages, and is subject to the fulfillment of certain conditions. EMI previously paid an advance of approximately $50 million towards the purchase price of the land, p
'/>"/>

SOURCE Elbit Medical Imaging Ltd.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Medical College receives $377K to study brain disease
2. Barriers will not stop convergence of medical technologies
3. Medical College team creates website for tracking flu
4. Biomedical engineering conference invites manufacturers
5. Visions: Wade offers straight talk on e-medical records
6. Merge unveils updated medical imaging software
7. Medical College receives $1.4M cancer grant
8. Medical technology firm lands $100K federal grant
9. Doyle outlines spending for Medical College, UWM
10. And the winners in medical design are
11. Manufacturing partnership will move into biotech and biomedical spaces

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)... , QUEBEC CITY, Dec. 2 /PRNewswire-FirstCall/...) (the "Company"), a global biopharmaceutical comp...ay announced that the U.S. Food and Drug Administr... the Company,s PI3K/Akt pathway inhibitor compound...psed/refractory multiple myeloma. Keryx Biopharmac...
(Date:12/1/2009)... Dr. Kerry Solomon announced ... has launched his redesigned website at www.DrKer...sulting Group. Dr. Solomon is a proven LASIK, len...n professionally recognized for his substantial co.... He is a member of Trusted LASIK Surgeons, which...
(Date:12/1/2009)... , NEW YORK, Dec. 1 Rep... report is available in its catalogue: ,, Emer...rket dynamics and the changing healthcare and regu....com/p0165658/Emerging-Clinical-Trial-Locations---...althcare-and-regulatory-environment.html ,, Ov...
(Date:12/1/2009)... , SHANGHAI, Dec. 1 /PRNewswire-Asia/ --...of ShangPharma, a leading China-based Contract Res...winner of the 2009 Deloitte,Technology Fast 50 Chi... high,tech companies in China. The award is a test...nue growth from 2006 to 2008. , The resul...
Breaking Biology Technology:AEterna Zentaris' Anti-Cancer Compound, Perifosine (KRX-0401), Receives FDA Fast Track Designation for the Treatment of Relapsed/Refractory Multiple Myeloma 2AEterna Zentaris' Anti-Cancer Compound, Perifosine (KRX-0401), Receives FDA Fast Track Designation for the Treatment of Relapsed/Refractory Multiple Myeloma 3Charleston LASIK and Cataract Expert Dr. Kerry Solomon Opens New Practice and Launches DrKerrySolomon.com 2Charleston LASIK and Cataract Expert Dr. Kerry Solomon Opens New Practice and Launches DrKerrySolomon.com 3Charleston LASIK and Cataract Expert Dr. Kerry Solomon Opens New Practice and Launches DrKerrySolomon.com 4Charleston LASIK and Cataract Expert Dr. Kerry Solomon Opens New Practice and Launches DrKerrySolomon.com 5Charleston LASIK and Cataract Expert Dr. Kerry Solomon Opens New Practice and Launches DrKerrySolomon.com 6Reportlinker Adds Emerging Clinical Trial Locations - Eastern Europe: Market Dynamics and the Changing Healthcare and Regulatory Environment 2Reportlinker Adds Emerging Clinical Trial Locations - Eastern Europe: Market Dynamics and the Changing Healthcare and Regulatory Environment 3Reportlinker Adds Emerging Clinical Trial Locations - Eastern Europe: Market Dynamics and the Changing Healthcare and Regulatory Environment 4Reportlinker Adds Emerging Clinical Trial Locations - Eastern Europe: Market Dynamics and the Changing Healthcare and Regulatory Environment 5Reportlinker Adds Emerging Clinical Trial Locations - Eastern Europe: Market Dynamics and the Changing Healthcare and Regulatory Environment 6Reportlinker Adds Emerging Clinical Trial Locations - Eastern Europe: Market Dynamics and the Changing Healthcare and Regulatory Environment 7Reportlinker Adds Emerging Clinical Trial Locations - Eastern Europe: Market Dynamics and the Changing Healthcare and Regulatory Environment 8Shanghai ChemPartner Ranks 3rd among 2009 Deloitte Technology Fast 50 China Winning Companies 2Shanghai ChemPartner Ranks 3rd among 2009 Deloitte Technology Fast 50 China Winning Companies 3
...ietary Products Division of Par Pharmaceutical wit...ortive Care, WOODCLIFF LAKE, N.J., Sept. 28 /PRNe...Inc. (NYSE: PRX ) today announced its commitment,...gs, through the,establishment and introduction of ...y pharmaceuticals division. Strativa Pharmaceutica...
...ORD, Mass., Sept. 28 Cynosure, Inc.,(Nasdaq: CYN...ad array of,light-based aesthetic treatment system...t the Leerink Swann & Company/MEDACorp Aesthetics ...mothy Baker will discuss Cynosure,s business,outlo...n a presentation,beginning at 2:10 p.m. ET Wednesd...
...IDGE, Mass., Sept. 28 Idenix,Pharmaceuticals, Inc...gaged,in the discovery and development of drugs fo...ounced a strategic restructuring. As part of the,r... agreement with Novartis,Pharma AG related to Tyze...,will discontinue all development, manufacturing a...
Other Biology Technology:Introducing Strativa Pharmaceuticals 2Introducing Strativa Pharmaceuticals 3Introducing Strativa Pharmaceuticals 4Introducing Strativa Pharmaceuticals 5Cynosure to Present at the Leerink Swann & Company/MEDACorp Aesthetics Roundtable Conference 2Idenix Pharmaceuticals Restructures to Concentrate Efforts on HCV and HIV Programs 2Idenix Pharmaceuticals Restructures to Concentrate Efforts on HCV and HIV Programs 3Idenix Pharmaceuticals Restructures to Concentrate Efforts on HCV and HIV Programs 4
(Date:12/1/2009)...Broadly speaking, ants have two different feeding ... "carnivorous," meaning that they are generalist p...ing on their remains. Some, however, are "herbivo...ts; rather, the bulk of their diets consist of pla...cky fluids produced by plants to attract ants, cal...
(Date:12/1/2009)...Particularly in Alzheimer,s disease, nerve cell de...w therapeutic options may possibly be derived from...m. These findings have been published in the curre...nce . Until only a few years ago, neurogenesis th...d to be impossible in the adult brain. The textboo...
(Date:12/1/2009)...Yehezkel Ben-Ari, winner of the 2009 Inserm Grand ...d its commitment to paying tribute to outstanding,...s. By honouring talents, Inserm intends to,demons...ved in today,s biological, medical and,health res...nd women who carry out and,drive this research ea...
Breaking Biology News(10 mins):Bacterial gut symbionts are tightly linked with the evolution of herbivory in ants 2New source discovered for the generation of nerve cells in the brain 2Yehezkel Ben-Ari, winner of the 2009 INSERM Grand Prix 2Yehezkel Ben-Ari, winner of the 2009 INSERM Grand Prix 3Aldrichimica Acta Ranked First in Organic Chemistry by Impact Factor 13555 1Aldrichimica Acta Ranked First in Organic Chemistry by Impact Factor 13555 2Service Corporation International Declares Quarterly Cash Dividend 54485 1Service Corporation International Declares Quarterly Cash Dividend 54485 2Service Corporation International Declares Quarterly Cash Dividend 54485 3Exercise May Help in Leukemia Recovery 54483 1Exercise May Help in Leukemia Recovery 54483 2
...light green light," winners are able to stop, and ...mrades. New research reveals that a similar race g...he big winner. , "The research provides new insigh...lps explain the impulsivity of people with attenti...uthor Jeffrey Schall, E. Bronson Professor of Neur...
...ssor of Medicine and Pharmacology at the Universit...ne has studied about 265 twin pairs over the past ...scoveries. , "By studying many traits and genes, w..." he said. , Studying genetic variations in twi...e heritable, or passed down through human DNA, ver...
...ing system in the brain has just been shown to be ...p; Science University study found. , The signaling...iming to reverse meth’s adverse health effects as ... , Working in the recently opened Program in Che...artment of Physiology and Pharmacology, scientists...
Other Biology News:Racing neurons control whether we stop or go 2Racing neurons control whether we stop or go 3Twin studies reveal genetic components leading to cardiac and kidney disease 2Twin studies reveal genetic components leading to cardiac and kidney disease 3OHSU lab finds meth receptor that could lead to therapy 2OHSU lab finds meth receptor that could lead to therapy 3
Concentrated Epitope Retrieval Buffer-Reduced pH from Bethyl Laboratories
GIBCO Donor Calf Serum from Invitrogen
...agicMark XP Western Protein Standards are specific...cular weight estimation directly on western blots....e, allowing direct visualization with the same ant...t protein on the blots. Colorimetric, chemilumines...
Genetic Mapping of Disease Genes from Promega
Biology Products: